Stock 1AI ALGORAE PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Algorae Pharmaceuticals Limited

Equities

1AI

AU0000296022

Biotechnology & Medical Research

Market Closed - Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
0.01 AUD 0.00% Intraday chart for Algorae Pharmaceuticals Limited -9.09% 0.00%
Mar. 08 Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform MT
Feb. 28 Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Valuation

Fiscal Period: Giugno 2018 2019 2020 2021 2022 2023
Capitalization 1 14.29 13.71 6.849 6.857 10.28 23.4
Enterprise Value (EV) 1 7.424 8.806 4.139 5.244 6.043 19.29
P/E ratio -35.7 x -4.29 x -7.06 x -4.62 x -3.58 x -9.38 x
Yield - - - - - -
Capitalization / Revenue 16.2 x 17.8 x 12.4 x 25.6 x 3,020 x 557 x
EV / Revenue 8.44 x 11.4 x 7.48 x 19.6 x 1,775 x 459 x
EV / EBITDA -2.83 x -3.51 x -2.28 x -3.92 x -4.14 x -15.2 x
EV / FCF -3.7 x -18.9 x -2.03 x -7.14 x -6.03 x -29.7 x
FCF Yield -27% -5.3% -49.2% -14% -16.6% -3.36%
Price to Book 2 x 3.31 x 2.38 x 4.98 x 2.55 x 6.22 x
Nbr of stocks (in thousands) 571,441 571,441 570,816 571,441 1,285,364 1,560,145
Reference price 2 0.0250 0.0240 0.0120 0.0120 0.007999 0.0150
Announcement Date 8/30/18 8/29/19 8/31/20 8/30/21 8/31/22 8/30/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Giugno 2018 2019 2020 2021 2022 2023
Net sales 1 0.8795 0.7697 0.5537 0.2682 0.003405 0.042
EBITDA 1 -2.628 -2.507 -1.813 -1.336 -1.459 -1.267
EBIT 1 -2.69 -2.559 -1.83 -1.341 -1.46 -1.268
Operating Margin -305.81% -332.51% -330.53% -500.05% -42,870.16% -3,016.91%
Earnings before Tax (EBT) 1 -0.5763 -3.478 -1.345 -1.905 -2.372 -2.108
Net income 1 -0.3745 -3.181 -0.9685 -1.461 -1.957 -2.108
Net margin -42.58% -413.34% -174.91% -544.62% -57,483.11% -5,016.32%
EPS 2 -0.000700 -0.005599 -0.001700 -0.002600 -0.002235 -0.001600
Free Cash Flow 1 -2.006 -0.4668 -2.035 -0.735 -1.002 -0.6486
FCF margin -228.05% -60.64% -367.55% -274.06% -29,427.14% -1,543.58%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/30/18 8/29/19 8/31/20 8/30/21 8/31/22 8/30/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 6.86 4.91 2.71 1.61 4.24 4.11
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -2.01 -0.47 -2.04 -0.73 -1 -0.65
ROE (net income / shareholders' equity) -5.11% -56.4% -27.6% -68.6% -72.3% -54.1%
ROA (Net income/ Total Assets) -20.6% -23.9% -25% -33.3% -30.8% -18.7%
Assets 1 1.816 13.29 3.874 4.386 6.346 11.29
Book Value Per Share 2 0.0100 0.0100 0.0100 0 0 0
Cash Flow per Share 2 0.0100 0.0100 0.0100 0 0 0
Capex 1 0 0.01 - - 0 -
Capex / Sales 0.34% 1.34% - - 111.69% -
Announcement Date 8/30/18 8/29/19 8/31/20 8/30/21 8/31/22 8/30/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ALGORAE PHARMACEUTICALS LIMITED Stock Algorae Pharmaceuticals Limited
0.00% 11M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 1AI Stock
  4. Financials Algorae Pharmaceuticals Limited